(Q30649483)

English

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Databa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrea Janikova

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

David Salek

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Pavla Vesela

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ludmila Boudova

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Milada Jankovska

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jan Pirnos

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mojmir Moulis

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Roman Kodet

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Michal Michal

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Eva Janousova

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jan Muzik

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jiri Mayer

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

13 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

55

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

802-810

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle c

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.815349

21 January 2018

Identifiers

10.3109/10428194.2013.815349

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23772666%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30649483&oldid=1561117266"